A strong and supported pharma industry is central to Ireland's economic recovery, says trade body

25 May 2010

Citing the Irish Pharmaceutical Healthcare Association's (IPHA) latest edition of its Pharmaceutical Healthcare Facts and Figures 2010, Gerald Farrell, the IPHA's president stated: 'It is clear...that the international research-based pharmaceutical industry's footprint spans the entire island of Ireland.'

Speaking at the launch of the publication, which presents an overview of health care in Ireland and the pharmaceutical industry both nationally and globally, Dr Farrall said: 'Every day the industry plays a vital role in the lives of Irish patients and consumers. When they fall ill - whether it's with a cold or something more serious - it is likely that they will take a medicine or treatment to help them get better. Not only that, our industry has key role to play in helping the Irish economy get better too.'

He noted that the Irish government has spoken of its desire to create an 'Innovation Island' and how this is central to the nation's economic recovery. 'The international research-based pharmaceutical industry has been a key driver of our economy over the last 40 years. This sector sees, in Ireland, a country which is open for our business and responsive to our needs. That's why right now we employ more than 24,500 people directly and as many again indirectly. It also explains why we are the largest contributors to corporation tax and why pharmaceuticals, along with chemicals and medical products, account for over 50% of Irish exports,' the IPAH president pointed out.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical